Literature DB >> 12030659

The impact of a general practice group intervention on prescribing costs and patterns.

Jane Walker1, Nigel Mathers.   

Abstract

BACKGROUND: The formation of primary care groups (PCGs) and trusts (PCTs) has shifted the emphasis from individual practice initiatives to group-based efforts to control rising prescribing costs. However, there is a paucity of literature describing such group initiatives. We report the results of a multilevel group initiative, involving input from a pharmaceutical adviser, practice comparison feedback, and peer review meetings. AIM: To determine the impact of a prescribing initiative on the prescribing patterns of a group of general practices. DESIGN OF STUDY: A comparative study with non-matched controls.
SETTING: Nine semi-rural/rural practices forming a commissioning group pilot, later a PCG, in Southern Derbyshire with nine practices as controls.
METHOD: Practice data were collated for overall prescribing and for therapeutic categories, between the years 1997/1998 and 1998/1999 and analysed statistically. Prescribing expenditure trends were also collated.
RESULTS: Although both groups came well within their prescribing budgets, in the study group this was for the first time in five years. Their rate of increase in expenditure slowed significantly following the initiative compared with that of the comparison group, which continued to rise (median practice net ingredient cost/patient unit (nic/PU) increase: Pound Sterling0.69 and Pound Sterling3.80 respectively; P = 0.03). The study group's nic/PU dropped below, and stayed below, that of the comparison group one month after the start of the initiative. For most therapeutic categories the study group had lower increases in costs and higher increases in percentage of generic items than the comparison group. Quality markers were unaffected.
CONCLUSION: We suggest that practices with diverse prescribing patterns can work together effectively within a PCT locality to control prescribing costs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030659      PMCID: PMC1314236     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  20 in total

1.  Generic prescribing: time to regulate the market? Price rises are a blow to nascent primary care groups.

Authors:  T Walley; P Burrill
Journal:  BMJ       Date:  2000-01-15

2.  Sore throats and antibiotics. Applying evidence on small effects is hard; variations are probably inevitable.

Authors:  C Del Mar
Journal:  BMJ       Date:  2000-01-15

3.  Government orders inquiry as price of generic drugs soars.

Authors:  J Jones
Journal:  BMJ       Date:  1999-10-30

4.  The implementation of evidence-based medicine in general practice prescribing.

Authors:  C Salisbury; N Bosanquet; E Wilkinson; A Bosanquet; J Hasler
Journal:  Br J Gen Pract       Date:  1998-12       Impact factor: 5.386

5.  Impact of feedback and peer review on prescribing.

Authors:  F M Haaijer-Ruskamp; P Denig
Journal:  Occas Pap R Coll Gen Pract       Date:  1995-02

6.  Can rational prescribing be summatively assessed?

Authors:  G Buckley; J Allen
Journal:  Occas Pap R Coll Gen Pract       Date:  1995-02

Review 7.  Implementing guidelines and innovations in general practice: which interventions are effective?

Authors:  M Wensing; T van der Weijden; R Grol
Journal:  Br J Gen Pract       Date:  1998-02       Impact factor: 5.386

8.  What can PACT tell us about prescribing in general practice?

Authors:  A Majeed; N Evans; P Head
Journal:  BMJ       Date:  1997-12-06

9.  How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study.

Authors:  T Rafferty; K Wilson-Davis; H McGavock
Journal:  BMJ       Date:  1997-07-19

10.  Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia.

Authors:  D L O'Connell; D Henry; R Tomlins
Journal:  BMJ       Date:  1999-02-20
View more
  4 in total

1.  Results of a 12-month quality-circle prescribing improvement programme for GPs.

Authors:  Françoise Riou; Christine Piette; Gérard Durand; Jacques Chaperon
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

2.  Biosimilar medicines uptake: The role of the clinical pharmacist.

Authors:  Roland Nnaemeka Okoro
Journal:  Explor Res Clin Soc Pharm       Date:  2021-04-07

3.  Mystery shopping in health service evaluation.

Authors:  Helen Moriarty; Deborah McLeod; Anthony Dowell
Journal:  Br J Gen Pract       Date:  2003-12       Impact factor: 5.386

Review 4.  Behaviour change interventions to promote prescribing of generic drugs: a rapid evidence synthesis and systematic review.

Authors:  Thirimon Moe-Byrne; Duncan Chambers; Melissa Harden; Catriona McDaid
Journal:  BMJ Open       Date:  2014-05-14       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.